Manufacturer record
Clevus Lifesciences: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Clevus Lifesciences (Himachal Pradesh) were declared Not of Standard Quality between July 2021 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: UT-1821, Albendazole Tablets IP 400 mg (exp Jan 2027). RDTL, Bellary, Karnataka (state lab) found it not of standard quality: Test for Dissolution. Listed in the September 2026 alert.
Records by type
3 records linked to Clevus Lifesciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Albendazole Tablets IP 400 mg | Batch UT-1821Mfg Feb 2025 · Exp Jan 2027 | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab | Sep 2026 |
| Bupropion Hydrochloride Extended Release Tablets USP 150 mg (BUPIDEP-150 ER TABLETS) | Batch CT-12330321Mfg Mar 2021 · Exp Aug 2022 | DissolutionDissolution | RDTL ChandigarhState lab | Aug 2021 |
| Fexofenadine Tablets I.P. 120 mg | Batch CT-8321220Mfg Dec 2020 · Exp Nov 2022 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.